View in EDS

World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors.

Saved in:

Bibliographic Details
Title:	World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors.
Authors:	Dexter T; Anthony Nolan, London, United Kingdom. Electronic address: Tania.dexter@anthonynolan.org., Perera K; Welsh Bone Marrow Donor Registry, Wales, United Kingdom., Trillos AM; Spanish Bone Marrow Donor Registry, Barcelona, Spain., Sojo JF; Barcelona Cord Blood Bank, Barcelona, Spain., Ward J; South African Bone Marrow Registry, Cape Town, South Africa., Lachance S; Héma-Québec Stem Cell Donor Registry, Montreal, Canada., Van Eerden E; World Marrow Donor Association, Leiden, Netherlands., Bengtsson M; Tobias Registry, Stockholm, Sweden., Pollichieni S; Italian Bone Marrow Donor Registry, Genoa, Italy., Hsu YM; Gift of Life Marrow Registry, Florida, USA., Mengling T; DKMS Group, Tübingen, Germany., Rieping J; DKMS Collection Centre, Dresden, Germany., Anthias C; Anthony Nolan, London, United Kingdom., Bemis A; National Marrow Donor Program, Minneapolis, USA., Cody M; National Marrow Donor Program, Minneapolis, USA.
Source:	Transplantation and cellular therapy [Transplant Cell Ther] 2026 May; Vol. 32 (5), pp. 551.e1-551.e6. Date of Electronic Publication: 2026 Jan 23.
Publication Type:	Journal Article
Journal Info:	Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE; In Process
Database:	MEDLINE Ultimate

Description
ISSN:	2666-6367
DOI:	10.1016/j.jtct.2026.01.021